Atlas Trials

Single Dose ADME Study of [14C]SJP-0008 in Healthy Male Subjects

Clinical trial NCT05320861 · COMPLETED

Trial details

NCT number
NCT05320861
Sponsor
Senju Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2021-09-24
Primary completion
2021-11-02
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.